Ontex Group (ONTEX) Q3 2025 earnings summary

Executive summary

• Q3 revenue was €445 million, up 3.7–4% sequentially from Q2, driven by new contract wins and transformation program execution, despite a 3.8–5% year-over-year decline due to soft market demand.

• Adjusted EBITDA margin improved by 3 percentage points quarter-on-quarter to 11.4%, though it was 0.6pp lower year-over-year.

• Leverage remained stable at 2.7x, with net debt reduced by €9 million to €543 million at quarter-end.

• Positive free cash flow in Q3 was supported by EBITDA delivery, cost savings, and no significant restructuring cash out.

• Full-year outlook is maintained despite ongoing soft market conditions.

Financial highlights

• Q3 revenue was €445 million, down 3.8–5% year-over-year, mainly due to lower volumes in private label and baby care.

• Adjusted EBITDA for Q3 reached €51 million, with €16 million net cost savings offsetting cost increases.

• Operating profit was €29 million, including €2 million in one-time restructuring costs.

• Free cash flow was positive, contributing to a €9 million reduction in net debt.

• Adjusted EBITDA margin was 11.4%, down 0.6pp year-over-year but up 3pp from Q2.

Outlook and guidance

• Q4 revenue is projected to grow 5% sequentially, mainly from new contract wins in Europe and North America.

• Q4 adjusted EBITDA is expected to increase by at least €30 million sequentially, driven by volume growth and further cost optimization.

• Full-year revenue is expected to be down low single digits like-for-like, with adjusted EBITDA in the €200–210 million range.

• Free cash flow for the year is expected to break even, with net debt and leverage ratio improving to about 2.5x by year-end.

• Sequential improvement in revenue and adjusted EBITDA anticipated in Q4, driven by new contracts and continued cost improvements.